MG
TARO

Michael Gelband’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Michael Gelband’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,894
Closed -$870K – 1755
2019
Q4 		$870K Buy
+9,894
New +$834K 0.02% 612

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Michael Gelband's TARO Position: Q1 2020 in Review

Michael Gelband sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2020, closing a stake of 9,894 shares — an estimated $870K sold.

Michael Gelband first reported a position in TARO in Q4 2019 and held it in 1 quarter. The position peaked at $870K in Q4 2019. 90 funds tracked by Wall St. Rank hold TARO as of Q1 2020.

  • Michael Gelband reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2020 after selling out during the quarter.
  • Michael Gelband sold 9,894 Taro Pharmaceutical Industries Ltd. shares in Q1 2020, an estimated $870K.
  • Michael Gelband first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2019 and held it in 1 quarter.
  • Michael Gelband's Taro Pharmaceutical Industries Ltd. position peaked at $870K in Q4 2019.
  • 90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2020.

Based on ExodusPoint Capital Management's 13F filing for Q1 2020, filed 15 May 2020.